Abstract
186TiP - An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy: EDEN trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have